Differential effects of a stem cell factor-immunoglobulin fusion protein on malignant and normal hematopoietic cells

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2924-2930

  Erben, Ulrike ^a   Thiel, Eckhard ^a   Notter, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G1; STEM CELL FACTOR;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL; PRIORITY JOURNAL;

ANIMALS; CELL ADHESION; CELL DIVISION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-KIT; RECOMBINANT FUSION PROTEINS; STEM CELL FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033564096     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Broudy, V. C. Stem cell factor and hematopoiesis. Blood, 90: 345-1364, 1997.
2. Brugger, W., Heimfeld, S., Berenson, R. J., Mertelsmann, R., and Kanz, L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med., 333: 283-287, 1995.
3. Weaver, A., Ryder, D., Crowther, D., Dexter, T. M., and Testa, N. G. Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood, 88: 3323-3328, 1996.
4. Hsu, Y. R., Wu, G. M., Mendiaz, E. A., Syed, R., Wypych, J., Toso, R., Mann, M. B., Boone, T. C., Narhi, L. O., Lu, H. S., and Langley, K. E. The majority of stem cell factor exists as a monomer under physiological conditions: implications for dimerization mediating biological activity. J. Biol. Chem., 272: 6406-6415, 1997.
5. d mutant. Cell, 64: 1025-1035, 1991.
6. Brannan, C. I., Lyman, S. D., Williams, D. E., Eisenman, J., Anderson, D. M., Cosman, D., Bedell, M. A., Jenkins, N. A., and Copeland, N. G. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmatic domains. Proc. Natl. Acad. Sci. USA, 88: 4671-4677, 1991.
7. Coulombel, L., Kalousek, D. K., Eaves, C. J., Gupta, C. M., and Eaves, A. C. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome positive chronic myelogenous leukemia. N. Engl. J. Med., 308: 1493-1498, 1983.
8. Udomsakdi, C., Eaves, C. J., Swolin, B., Reid, D. S., Barnett, M. J., and Eaves, A. C. Rapid decline of chronic myeloid leukemia cells in long-term culture due to a defect at the leukemic stem cell level. Proc. Natl. Acad. Sci. USA, 89: 6192-6196, 1992.
9. Wineman, J. P., Nishikawa, S. I., and Müller-Sieburg, C. E. Maintenance of high levels of pluripotent hematopoietic stem cells in vitro: effect of stromal cells and c-kit. Blood, 81: 365-372, 1993.
10. Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I. K., Jacobsen, F. W., Mendiaz, E. A., Birkett, N. C., Smith, K. A., Johnson, M. J., Parker, V. P., Flores, J. C., Patel, A. C., Fisher E. F., Erjavec, H. O., Herrera, C. J., Wypych, J., Sachdev, R. K., Pope, J. A., Leslie, I., Wen, D., Lin, C. H., Cupples, R. L., and Zsebo, K. M. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell, 63: 203-211, 1990.
11. Seed, B., and Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA, 84: 3365-3369, 1987.
12. Kunzendorf, U., Pohl, T., Bulfone-Paus, S., Krause, H., Notter, M., Onu, A., Walz, G., and Diamantstein, T. Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice. J. Clin. Invest., 97: 1-7, 1996.
13. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
14. Avanzi, G. C., Brizzi, M. F., Giannotti, J., Ciarletta, A., Yang, Y. C., Pegoraro, L., and Clark, S. C. M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J. Cell. Physiol., 145: 458-464, 1990.
15. Nelson, B. H., Lord, J. D., and Greenberg, P. D. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature (Lond.), 369: 333-336, 1994.
16. Toksoz, D., Zsebo, K. M., Smith, K. A., Hu, S., Brankow, D., Suggs, S. V., Martin, F. H., and Williams, D. A. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product. Proc. Natl. Acad. Sci. USA, 89: 7350-7354, 1992.
17. d mutant. Cell, 64: 1025-1035, 1991.
18. Williams, D. A., Rios, M., Stephens, C., and Patel, V. P. Fibronectin and VLA-4 in hematopoietic stem cell-microenvironment interactions. Nature (Lond.), 352: 438-441, 1991.
19. Simmons, P. J., Masinovsky, B., Longenecker, B. M., Berenson, R., Torok-Storb, B., and Gallantin, W. M. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80: 388-395, 1992.
20. FAK) and paxillin. Blood, 89: 1574-1584, 1997.
21. Limdblad, A., Steller, R., Kabat, E. A., Hirst, J. W., Weigert, M. G., and Cohn, M. Immunochemical studies on mouse myeloma proteins with specifity for dextran or for levan. Immunochemistry, 9: 535-544, 1972.
22. Bulfone-Paus, S., Ungureanu, D., Pohl, T., Lindner, G., Paus, R., Rückert, R., Krause, H., and Kunzendorf, U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med., 3: 1124-1128, 1997.
23. Huang, E. J., Nocka, K. H., Buck, J., and Besmer, P. Differential expression and processing of two cell associated form of the kit-ligand: KL-1 and KL-2. Mol. Biol. Cell., 3: 349-352, 1992.
24. Lu, H. S., Jones, M. D., Shieh, J. H., Mendiaz, E. A., Feng, D., Watler, P., Narhi, L. O., and Langley, K. E. Isolation and characterization of a disulfide-linked human stem cell factor dimer. J. Biol. Chem., 271: 11309-11316, 1996.
25. Miyazawa, K., Williams, D. A., Gotoh, A., Nishimaki, J., Broxmeyer, H. E., and Toyama, K. Membrane-bound steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood, 85: 641-649, 1995.
26. Miyazawa, K., Toyama, K., Gotoh, A., Hendrie, P. C., Mantel, C., and Broxmeyer, H. E. Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M-07e cells. Blood, 83: 137-145, 1994.
27. Barnett, M. J., Eaves, C. J., Phillips, G. L., Gascoyne, R. D., Hogge, D. E., Horsman, D. E., Humphries, R. K., Klingemann, H. G., Lansdorp, P. M., Nantel, S. H., Reece, D. E., Shepherd, J. D., Spinelli, J. J., Sutherland H. J., and Eaves, A. C. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood, 84: 724-732, 1994.
28. Dexter, T. M., and Chang, J. New strategies for the treatment of chronic myeloid leukemia. Blood, 84: 673-675, 1994.
29. Weber, M. C., and Tykocinski, M. L. Bone marrow stromal cell blockade of human leukemic cell differentiation. Blood, 83: 2221-2229, 1994.
30. Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., Widmer, M. B., and Blosch, C. M. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med., 337: 141-147, 1997.
31. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. A. L., Ledbetter, J. A., Singh, C., and Tepper, M. A. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (Washington DC), 257: 792-794, 1992.